<p>Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report</p>

Abstract

Adverse drug reactions are crucial events related to drug usage that ought to be reported and the effects of which can be minimized by careful and vigilant use of drugs. Pharmacovigilance refers to the systematic practice of reporting, assessing and preventing such events. Although such practice is vital in any healthcare system, its actual implementation has been found to be very limited in a country like Nepal. With the aim of disseminating information about such events and the role of healthcare professionals in pharmacovigilance, a one-day workshop was organized with international and national speakers on this subject at Nepal Cancer Hospital and Research Center, Lalitpur, Nepal, which also has a regional pharmacovigilance center. The workshop included lectures and hands-on training and had an audience from diverse fields of healthcare such as pharmacy, medical, surgical and radiation oncology, pathology and nursing staff. The feedback from the participants revealed that practical demonstration and hands-on training with extensive topic coverage were the best feature of the workshop, while less interaction during the lectures was a source of dissatisfaction with a recommendation to conduct more events focused on similar topics in the future.

Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update

“…This seems to indicate that there have been no significant advances in the training of health professionals on ADR since ignorance and complacency are potentially modified through training on undergraduate[ 81 , 82 ] and postgraduate pharmacovigilance education [ 81 ]. In this sense, educational sessions (workshops or lectures) [ 83 – 87 ] showed a positive impact on ADR reporting. Nonetheless, the increased rate of SR originated was shown to decrease over time [ 83 , 84 , 88 ].…”

Exploration of Perception, Need and Barriers against Pharmacovigilance and Adverse Drug Reactions Reporting: Healthcare Professionals’ Insight

“…PV actually opens the new horizon for the patient and drug safety for the last 2 decades. However; it has taken many other disciplines into it including research, product development and pharmaceuticals [4,5]. Drug safety and monitoring activities were first launched by WHO after the world worst disaster of thalidomide in 1960s [6].…”